《港樓》沙田「富豪.山(峰)」獲大手客斥6,139萬購入兩伙四房戶
百利保(00617.HK)及富豪酒店(00078.HK)旗下沙田九肚豪宅項目「富豪.山(峰)」連續三周錄得成交,昨日(2日)透過招標形式,向同一名買家售出兩個分層戶單位,成交價合共6,138.5萬元。
兩個單位分別為第5座8樓A室及第5座8樓B室,均屬四房兩套間隔,實用面積分別為1,623平方呎及1,612平方呎,成交價分別為3,190.3萬元及2,948.2萬元,呎價約19,657元及18,289元,成交期180日。
富豪物業代理董事衛振聲表示,項目近期成交暢旺,過去兩個月內已售出1個洋房及5個分層戶單位,套現超過3億元。由於樓市氣氛持續向好,他相信買家將紛紛加快入市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.